Our company was founded in 1988 in Bialystok and is a licensed pharmaceutical wholesaler.
We provide health care facilities with products and means to maintain hygiene, consumables for sterilization processes, in the washer-disinfectors and medical sterilizers, as well as in dental surgeries with modern dental, prosthetic and surgical materials.
We also provide specialist advice in the design of technologies for medical equipment, both at office sterilization points, local sterilizers and central sterilizers.
Hygiene and disinfection are areas in which our company has been specializing for almost 25 years. Through training we promote the latest global standards in the field of hygiene, preventing the spread of infections (including nosocomial infections). Contact with authorities in this field in the country as well as on the international forum allows us to raise our knowledge and pass it on to others.
Our suppliers are producers from Europe, Canada, Israel, USA, Taiwan, and our recipients of health care facilities as well as numerous recipients from other sectors of the economy.
46.46.Z - Wholesale of pharmaceutical goods
20.4 - Manufacture of soap and detergents, cleaning and polishing preparations, perfumes and toilet preparations
20.5 - Manufacture of other chemical products
46.1 - Wholesale on a fee or contract basis
46.90.Z - Non-specialised wholesale trade
47.1 - Retail sale in non-specialised stores
47.7 - Retail sale of other goods in specialised stores
52.1 - Warehousing and storage
85.5 - Other education
86.90.E - Other human health activities notelsewhere classified
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Net sales | 8 | 9,1 | 6,4 | -29 |
Liabilities and provisions | 2,7 | 2,9 | 1,7 | -41,9 |
Equity | 0,5 | 1 | 1,2 | 22,2 |
Total assets | 3,2 | 3,8 | 2,8 | -26 |
Cash and cash equivalents | 0,5 | 0,9 | 0,7 | -21,9 |
Depreciation | 0,1 | 0,1 | 0,1 | -15,2 |
Gross profit / loss | -0,1 | 0,6 | 0,3 | -51,5 |
EBITDA | -0,1 | 0,6 | 0,3 | -44 |
Current assets | 2,9 | 3,6 | 2,6 | -26,4 |
Operating profit (EBIT) | -0,1 | 0,5 | 0,3 | -47,7 |
Net profit / loss | -0,1 | 0,5 | 0,3 | -47,1 |
% | % | % | p.p. | |
Return on equity (ROE) | -19,1 | 50 | 21,6 | -28,4 |
Return on sales (ROS) | -1,1 | 5,2 | 3,9 | -1,3 |
Equity ratio | 14,9 | 24,9 | 41,1 | 16,2 |
EBITDA margin | -0,6 | 6,7 | 5,3 | -1,4 |
Gross profit margin | -1,1 | 6,6 | 4,5 | -2,1 |
Days | Days | Days | Days | |
Current liabilities turnover ratio | 120 | 107 | 92 | -15 |
Current ratio | 1,1 | 1,4 | 1,6 | 0,2 |
Net debt to EBITDA | 7,7 | -0,8 | -1,7 | -0,9 |